price
EL
NASDAQ · ELTX
Elicio Therapeutics, Inc.
Healthcare · Biotechnology
$1.79
Up+$0.02 (+1.13%)
Updated Oct 15, 2026, 2:08 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 144.37M
- P/E ratio
- -3.04
- Dividend yield
- 0.00%
- 52-week range
- $1.71 – $16.00
- Volume
- 373.27K
- Avg. volume
- 97.45K
Price performance · ELTX
ELTX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 13, 2026
ELTX closed at $1.77 after 20 trading sessions, up 0.00% for the selected period.
- Last close
- $1.77
- Period change
- +0.00%
- Period low
- $1.77
- Period high
- $1.92
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 13, 2026 | $1.88 | $1.88 | $1.73 | $1.77 | 232.25K |
| Oct 12, 2026 | $1.90 | $1.91 | $1.82 | $1.88 | 164.36K |
| Oct 9, 2026 | $1.83 | $1.92 | $1.785 | $1.89 | 306.2K |
| Oct 8, 2026 | $1.85 | $1.85 | $1.74 | $1.81 | 267.28K |
| Oct 7, 2026 | $1.87 | $1.92 | $1.83 | $1.85 | 138.94K |
| Oct 6, 2026 | $1.90 | $1.96 | $1.86 | $1.88 | 259.1K |
| Oct 5, 2026 | $1.93 | $1.96 | $1.81 | $1.92 | 202.85K |
| Oct 2, 2026 | $1.95 | $1.97 | $1.85 | $1.92 | 175.96K |
| Oct 1, 2026 | $1.82 | $1.9599 | $1.82 | $1.92 | 311.26K |
| Sep 30, 2026 | $1.86 | $1.86 | $1.78 | $1.82 | 274.03K |
| Sep 29, 2026 | $1.85 | $1.90 | $1.77 | $1.84 | 452.47K |
| Sep 28, 2026 | $1.85 | $1.90 | $1.81 | $1.85 | 222.07K |
| Sep 25, 2026 | $1.88 | $1.90 | $1.82 | $1.84 | 165.36K |
| Sep 24, 2026 | $1.88 | $2.00 | $1.81 | $1.88 | 339.77K |
| Sep 23, 2026 | $1.87 | $1.895 | $1.84 | $1.87 | 195.35K |
| Sep 22, 2026 | $1.92 | $1.925 | $1.82 | $1.87 | 404.04K |
| Sep 21, 2026 | $1.92 | $2.02 | $1.91 | $1.91 | 484.46K |
| Sep 18, 2026 | $1.86 | $2.00 | $1.86 | $1.89 | 689.74K |
| Sep 17, 2026 | $1.79 | $1.90 | $1.785 | $1.865 | 340.17K |
| Sep 16, 2026 | $1.90 | $1.90 | $1.705 | $1.77 | 629.87K |
Latest ELTX news
The latest Smart Investors Daily articles mentioning ELTX.
Stock researchCompany · Overview
Company
Market Activity
Research & News
Loading stock research…

